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Abstract Damage to myelinated axons contributes to neuro-
logical deficits after acute CNS injury, including ischemic and
hemorrhagic stroke. Potential treatments to promote re-
myelination will require fully differentiated oligodendrocytes,
but almost nothing is known about their fate following intra-
cerebral hemorrhage (ICH). Using a rat model of ICH in the
striatum, we quantified survival, proliferation, and differenti-
ation of oligodendrocyte precursor cells (OPCs) (at 1, 3, 7, 14,
and 28 days) in the peri-hematoma region, surrounding stria-
tum, and contralateral striatum. In the peri-hematoma, the
density of Olig2+ cells increased dramatically over the first
7 days, and this coincided with disorganization and fragmen-
tation of myelinated axon bundles. Very little proliferation
(Ki67+) of Olig2+ cells was seen in the anterior subventricular
zone from 1 to 28 days. However, by 3 days, many were
proliferating in the peri-hematoma region, suggesting that lo-
cal proliferation expands their population. By 14 days, the
density of Olig2+ cells declined in the peri-hematoma region,
and, by 28 days, it reached the low level seen in the contralat-
eral striatum. At these later times, many surviving axons were
aligned into white-matter bundles, which appeared less
swollen or fragmented. Oligodendrocyte cell maturation was
prevalent over the 28-day period. Densities of immature OPCs
(NG2+Olig2+) and mature (CC-1+Olig2+) oligodendrocytes in
the peri-hematoma increased dramatically over the first week.
Regardless of the maturation state, they increased preferential-
ly inside the white-matter bundles. These results provide evi-
dence that endogenous oligodendrocyte precursors proliferate
and differentiate in the peri-hematoma region and have the
potential to re-myelinate axon tracts after hemorrhagic stroke.
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Introduction
Intracerebral hemorrhage (ICH) comprises 10–20 % of all
stroke cases [1] and is a result of spontaneous rupture of brain
arterioles, which produces a hematoma in the brain parenchy-
ma. The overall mortality rate is ∼40% by 1 month [2], >70%
at 5 years [3], and few survivors regain functional indepen-
dence [4]. With no drug therapies in clinical use, current treat-
ment focuses on supportive care and reducing the impact of
the damage [5, 6]. The primary injury phase occurs within
minutes to hours after the onset of bleeding, and during this
time, the hematoma causes local tissue destruction [7, 8].
Then, cellular debris and breakdown of blood components
initiate a secondary injury phase, which can last for days to
weeks in the peri-hematoma region adjacent to the hematoma
[7, 8].
Following ICH, brain cells of all types die inside the he-
matoma, which forms a non-vascularized blood clot.
Therapeutic approaches to treating ICH therefore focus on
the peri-hematoma region surrounding the lesion, and on
preventing damage from spreading. In the peri-hematoma, in
addition to neuronal injury, white matter is damaged but po-
tentially rescuable. In humans, white-matter damage was re-
ported in 77 % of ICH patients [9]. Most preclinical, animal
studies of ICH have focused on graymatter [10, 11], with very
little research on white-matter damage and its progression.
CNS white matter is comprised of axons, myelin sheaths that
enwrap them, and oligodendrocytes, the cells that produce
myelin [12]. Myelinated axons are essential for CNS commu-
nication, with millions of afferent and efferent axons arranged
in white-matter tracts. Because of its crucial role, even small
white-matter lesions can produce devastating neurological
deficits [13]. Functional recovery and efficacy of potential
treatments will require both axon survival and re-myelination.
Hypertensive ICH often occurs in the human striatum [14].
We have been exploiting the well-established collagenase
model of ICH in the rat striatum and previously found that
progressive, extensive damage to myelin bundles and axons
during the first week correlated temporally and spatially with
inflammation and microglial activation [15–18]. However, the
fate of axons and oligodendrocytes is not known. In order to
identify therapeutic targets for rescuing white matter after
ICH, a deeper understanding of the cellular pathology is need-
ed. The paucity of information raises several important ques-
tions. Do oligodendrocyte-lineage cells remain in the dam-
aged region after ICH? If so, do they proliferate and remain
as non-myelinating oligodendrocyte precursor cells (OPCs),
or do they differentia te into mature cells? Does
oligodendrogenesis occur within the peri-hematoma? Here,
we addressed these questions from 1 to 28 days after
collagenase-induced ICH in the rat striatum.
Materials and Methods
Animals and Surgery
Male Sprague-Dawley rats weighing 300–350 g (Charles
River, Saint-Constant, Quebec, Canada) were randomly
assigned to either the saline control (n= 3) or ICH group
(n=3 or 4 per time point). They were housed at two rats per
cage in a temperature- and humidity-controlled room under a
diurnal light cycle (lights on from 6 am to 6 pm), and provided
with food and water ad libitum.
Surgical procedures were performed aseptically. Rats were
anesthetized with isoflurane (4 % induction, 2 % mainte-
nance), placed in a stereotaxic frame (David Kopf
Instruments, Tujungam, CA), and a 1-mm-diameter burr hole
was drilled into the skull 3.0 mm lateral and 0.1 mm anterior
to bregma. A 26-gauge needle attached to a micro-pump
(model UltraMicroPump II; World Precision Instruments,
Sarasota, FL) was inserted 6.0 mm deep from the surface of
the skull. Rats were injected with 0.5 μL of sterile 0.9 % saline
(controls) or saline containing 0.03 U of type IV collagenase
(Sigma-Aldrich, Oakville, Ontario, Canada) for experimental
ICH. The injection rate was 100 nL/min. The dose of collage-
nase was chosen after a titration pilot study so that the hema-
toma was restricted to the striatum, with sufficient tissue re-
maining to have regions of both peri-hematoma and surround-
ing striatum. The wound was closed with suture clips, and
Xylocaine was delivered subcutaneously near the injection
site to reduce post-operative pain. Body temperature was
maintained throughout the surgery and recovery period using
a thermostatic heating pad. All animals regained conscious-
ness within 10 min, and only rats with an ICH demonstrated
an ipsilateral turning bias. Their ability to eat, drink, and
groom themselves was not impaired, and no rats died because
of surgery or ICH induction.
Tissue Preparation
At 1, 3, 7, 14, or 28 days after surgery, rats were euthanized by
an overdose of isoflurane. They were perfused through the
heart with 150 mL of phosphate-buffered saline (PBS), follow-
ed by 150 mL of 4 % paraformaldehyde (pH 7.4). Brains were
removed, post-fixed in 4 % paraformaldehyde overnight, and
then placed in 10% sucrose for 24 h followed by 30 % sucrose
for 48 h. The brains were cut coronally or sagittally and em-
bedded in tissue-freezing medium (Ted Pella, Redding, CA).
Then, 16-μm-thick sections were cut using a cryostat (model
CM350S; Leica, Richmond Hill, Ontario, Canada), mounted
on glass slides, and stored at −40 °C until used.
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Cresyl Violet and Immunohistochemistry: Staining
and Analysis
Hematoma development at each time point was examined in
coronal and sagittal sections using cresyl violet. Frozen brain
sections were initially dehydrated in ethanol to remove phos-
pholipids and fixation chemicals [19] and then rehydrated in
distilled water for 1 min before adding 0.25 % cresyl violet
(Sigma-Aldrich) in a 200mM acetate buffer (pH 4.0) until well
stained [20]. The sections were immersed for 1 min in 0.25 %
glacial acetic acid in ethanol to differentiate the white matter,
incubated for 4 min in CitriSolv (Fisher Scientific, Pittsburgh,
PA) to clear the unstained tissue, and then mounted using DPX
(Sigma-Aldrich). Images were made using a flatbed scanner
(model HP Scanjet 4070; Hewlett-Packard, Palo Alto, CA).
Immunohistochemistry was used to examine the extent of
white matter injury and the density, proliferation, and differen-
tiation of oligodendrocyte-lineage cells. Frozen brain sections
were thawed at room temperature and rehydrated for 20 min in
a buffer containing 1 M PBS at pH 7.5 (Wisent Bioproducts,
St-Bruno, Quebec, Canada), 0.1 % bovine serum albumin
(Sigma-Aldrich), and 0.2 % Triton X-100 (Sigma-Aldrich)
(PBT). To reduce nonspecific antibody binding, sections were
blocked for 2 h in PBT containing 10 % donkey serum
(Jackson ImmunoResearch, Baltimore, PA). For staining, sec-
tions were incubated overnight at room temperature in PBT
buffer containing 5 % donkey serum and two or three of the
following primary antibodies.
To assess myelin and white-matter tracts, we used poly-
clonal antibodies directed against myelin basic protein
(MBP), i.e., rabbit anti-MBP (1:1000; ab40390, Abcam,
Toronto, Ontario, Canada) or chicken anti-MBP (1:400;
ab106583, Abcam). Axons were labeled with a mouse mono-
clonal antibody against pan-axonal neurofilaments (pan-NF;
1:1000; 837901, Covance, Montreal, Quebec, Canada). To
label all oligodendrocyte-lineage cells, we used antibodies
against Boligodendrocyte lineage transcription factor 2^
(Olig2), either rabbit polyclonal anti-Olig2 (1:500; AB9610,
Millipore, Etobicoke, Ontario, Canada) or mouse monoclonal
anti-Olig2 (1:500; MABN50, Millipore). OPCs were identi-
fied by double staining with anti-Olig2 and a mouse mono-
clonal antibody against neural/glial antigen 2 (NG2) chondroi-
tin sulfate proteoglycan (1:500; MAB5384, Millipore). In the
adjacent serial brain section, mature oligodendrocytes were
identified by double staining with anti-Olig2 and a mouse
monoclonal antibody against adenomatous polyposis coli
(APC; also called CC-1; 1:500; OP80, Millipore). Cell prolif-
eration was monitored with a mouse antibody against Ki67
(1:100; ab15580, Abcam). After labeling with primary anti-
bodies, brain sections were washed in PBT (3×10 min) and
incubated with appropriate secondary antibodies for 2 h at
room temperature in the dark. Secondary antibodies (all from
Jackson ImmunoResearch) were applied at 1:200 dilution
(Alexa Fluor 488-conjugated donkey anti-mouse, Alexa
Fluor 594-conjugated donkey anti-rabbit, Dylight 405-
conjugated donkey anti-chicken) and were diluted in PBT
and 5 % donkey serum. To label cell nuclei, 4′-6-diamidino-
2-phenylindole (DAPI; 1:5000; Sigma-Aldrich) was applied
for 10 min. After washing in PBT (3×10 min), slides were
cover-slipped using Dako Fluorescent Mounting Medium
(Dako North America, Inc., Carpinteria, CA) and stored in
the dark at 4 °C. To minimize variability, immunohistochem-
istry for a given antibody combination was conducted on the
same day for all rats and time points using the same solutions.
Antibody-stained sections were examined using a confocal
microscope (model LSM700; Zeiss, Oberkochen, Germany)
and quantified using ImageJ software, version 1.48v
(National Institutes of Health, Bethesda, MD). Images used
within each figure were captured with the same pinhole size
and detector sensitivity settings, and with short exposure times
to avoid fading. Staining areas and cell counts were determined
in one coronal or sagittal section per animal, with four sample
boxes for each region examined (see schematic in Fig. 1). The
hematoma boundary was readily identified by the presence of
blood. All peri-hematoma sample boxes were placed immedi-
ately adjacent to the hematoma, with one side of each box
aligned with the hematoma boundary. When sampling the sur-
rounding ipsilateral striatum, each box was located beyond the
peri-hematoma boxes, ventral to the corpus callosum. For the
subventricular zone (SVZ), boxes were selected immediately
adjacent to the lateral ventricle starting in the dorsal-most re-
gion and moving ventrally. For the contralateral region, boxes
were randomly placed in the center of the striatum. When cells
were counted, all sample boxes were 320×320 μm for coronal
sections. The boxes were slightly larger (400×400 μm) for
sagittal sections because of variations in white-matter tract di-
ameter and density, and to have more tracts per image.
Data Analysis
Oligodendrocyte-lineage cells were quantified at 1, 3, 7, 14,
and 28 days after ICH. Cells were counted manually using
ImageJ software by an observer who was blinded to the time
point and location (i.e., peri-hematoma, surrounding striatum,
contralateral striatum). For coronal sections, counts from four
sampling boxes at each location and time were averaged, and
the mean±SEM was calculated from three rats at each time
point. To assess time-dependent changes within each region, a
one-way analysis of variance (ANOVA) was followed by
Tukey’s multiple-comparisons test. For sagittal sections, we
first quantified the number of cells inside versus outside
white-matter tracts in the peri-hematoma region. Then, the
area represented bywhite-matter tracts was calculated by sum-
ming the areas of each tract, outlined using the Polygon selec-
tion tool on ImageJ. The area outside the bundles was calcu-
lated by subtracting the area of the white-matter tracts from the
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total image area. Counts for oligodendrocyte-lineage cells
were converted to densities (number of cells/area). Values
are reported as mean ± SEM, from three or four rats at
each time point, and comparisons between inside versus
outside white-matter tracts were made with a two-way
ANOVA followed by Tukey’s multiple-comparisons test.
Throughout, differences were considered statistically sig-
nificant if p< 0.05.
Results
Myelin Is Damaged but Some Myelinated Axons Survive
in the Peri-hematoma After ICH
As expected, there was no hemorrhage in control, saline-
injected rats, while a hemorrhage developed when collagenase
was injected into the striatum (Fig. 1). At 1 day, collagenase
injection produced a large hematoma that was confined to the
striatum, and in both coronal (Fig. 1a) and sagittal (Fig. 1b)
sections, cell damage was apparent, as shown by reduced
cresyl violet staining of Nissl bodies. While a hematoma
was evident throughout the 28-day period, the area of dimin-
ished cresyl violet staining decreased with time and the blood
clot was gradually resorbed. In addition, the lateral ventricles
expanded (ventriculomegaly), which is a common outcome
after ICH and is due to impaired drainage of cerebrospinal
fluid (CSF) [21] or tissue loss [22]. Others, using the same
ICH model, have observed similar changes to the size of the
hematoma and ventricles for 28 days and longer [22, 23]. The
darker staining at 7 and 14 days is due to chromogenic iron
that is released from ruptured erythrocytes [24, 25]. In order to
quan t i fy changes in the spa t i a l d i s t r ibu t ion of
oligodendrocyte-lineage cells, we used coronal sections and
examined three regions: the peri-hematoma, surrounding stri-
atum, and contralateral striatum. Approximate sample loca-
tions are illustrated by the boxes in Fig. 1. Then, sagittal sec-
tions were used to quantify cells inside versus outside white-
matter bundles in the peri-hematoma region. The sample box-
es were slightly larger to visualize more bundles and a larger
proportion of each bundle.
To examine the progression of damage to axons and myelin
in a qualitative manner, we used coronal (Fig. 2a) and sagittal
(Fig. 2b) sections. Myelinated axon tracts in the striatum arise
from excitatory cortical neurons [26]. They were visualized
using an antibody against MBP, and axons were labeled with a
pan-NF antibody that recognizes the three major neurofila-
ment subunits: light, medium, and heavy chain. The coronal
sections show approximately circular myelinated axon tracts
extending in the rostral-caudal axis (Fig. 2a). In the saline-
injected (control) striatum, bundles are filled with densely
packed myelinated axons, as indicated by the abundant over-
lap of the MBP and pan-NF stains (Fig. 2a). At high magni-
fication, the two stains do not precisely co-localize (also see
[27]) because myelin wraps around each neurofilament-
containing axon. In sagittal sections from saline-injected ani-
mals, there were dense longitudinal tracts of myelinated axons
throughout the striatum (Fig. 2b). The sagittal orientation was
especially useful for assessing damage to white-matter bun-
dles close to the hematoma.
We previously showed a progressive, dramatic decrease in
staining for normal MBP and a concomitant increase in dam-
aged MBP in the peri-hematoma region from 1 to 7 days after
Fig. 1 Hematoma development in the first month after ICH.
Representative cresyl violet-stained sections from rats on day 1 after
saline injection (control) and on days 1, 3, 7, 14, and 28 after injection
of type IV collagenase into the right striatum. For day 7 after ICH, sample
boxes are shown for the peri-hematoma (red), surrounding ipsilateral
striatum (blue), and contralateral striatum (black). a Coronal sections.
The hematoma appears pale, which is especially clear on the right side
of the sections on days 1 and 3. On days 7 and 14, the hematoma is
smaller and darkly stained. b Sagittal sections. Scale bars= 1 mm
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ICH [16–18]. In coronal (Fig. 2a) and sagittal sections
(Fig. 2b), despite the normal variation in diameter of striatal
white-matter tracts, a similar increase in myelin damage is
clearly evident over the first week. There was progressive bun-
dle swelling and fragmentation. Interestingly, at 7 days, myelin
and axon staining were not well organized into dense bundles,
and the high-magnification coronal image shows diffuse neu-
rofilament staining inside fragmented bundles. Beyond the first
week, the bundles of myelinated axons appeared denser, less
swollen, and less fragmented (i.e., day 14was similar to day 3).
The high-magnification coronal image at 28 days clearly
shows that the axons were more aligned into dense myelinated
tracts. From the sagittal images, it appears that some bundles
were thinner at 14 and 28 days than in the saline control. The
improved appearance of the myelinated axon tracts after the
first week, and presence of both axons and myelin in the peri-
hematoma region throughout the first month after ICH, raises
the prospect for re-myelination. Thus, we next determined if
oligodendrocyte-lineage cells survived and differentiated into
mature cells that are capable of myelin production.
The Density of Oligodendrocyte-Lineage Cells Increases
as a Result of Proliferation in the Peri-hematoma Region
We quantified temporal changes in the density of
oligodendrocyte-lineage cells in the peri-hematoma region,
surrounding striatum, and undamaged contralateral striatum
from 1 to 28 days. All oligodendrocyte-lineage cells, regard-
less of maturation state, express the transcription factor, Olig2
[28], and, as expected, we found that Olig2 co-localized with
Fig. 2 Myelin damage and axon survival in the peri-hematoma after
ICH. Representative images of sections double-labeled with an
antibody against neurofilaments (pan-NF; green) and an antibody
against myelin basic protein (MBP; red). a Coronal sections from the
region adjacent to the hematoma, which is to the right but beyond the
image (as indicated by B→H^). The peri-hematoma is visible in the right-
most portion of each image, and the surrounding striatum is visible
toward the left. Higher-magnification images of the boxed regions are
shown to the right. b Sagittal sections. All images were taken in the
peri-hematoma, the region immediately adjacent to the hematoma,
which is below each portion shown (as indicated by B↓H^). Scale
bars= 50 μm and apply to all panels
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the nuclear marker, DAPI (Fig. 3a). It was previously shown
that saline injection does not cause damage [15, 25, 29, 30].
As expected, saline-injected controls showed the same density
of oligodendrocyte-lineage cells at 1, 3, and 7 days; hence,
ICH samples were compared with the 1-day saline control.
After ICH, the density of Olig2+ cells increased from 1 to
7 days in the peri-hematoma region, at which time they were
∼11-fold higher than controls (Fig. 3b) and formed a dense
band around the hematoma (Fig. 3a; inset to right). Their
numbers were markedly decreased at 14 and 28 days. In the
surrounding striatum further from the hematoma, and in the
contralateral striatum, the density of Olig2+ cells was elevated
at 1, 3, 7, and 14 days and then decreased to the control level at
28 days.
We examined sagittal sections from the peri-hematoma re-
gion to ask whether the oligodendrocyte-lineage cells
increased inside myelinated white-matter tracts, and in the
neuron-rich neuropil, which contains many cell bodies of me-
dium spiny neurons that are damaged after ICH [16–18, 31].
The bundles of myelinated axons were swollen and MBP was
degraded at 7 days, as previously shown. As shown in Fig. 2,
many myelinated bundles had re-appeared by 14 and 28 days
(Fig. 4a). Although Olig2+ cells were present both inside and
outside the bundles, they preferentially accumulated inside the
white-matter tracts (Fig. 4b). Again, their density peaked at
7 days and then decreased. Their density also apparently in-
creased outside the bundles (∼2-fold higher at 7 days) but this
did not reach statistical significance.
In principle, the increased density of Olig2+ cells observed
in the peri-hematoma region could be due to proliferation,
migration, or both. To address whether these cells were pro-
liferating within the damaged striatum, we labeled Ki67, a
Fig. 3 Numbers of oligodendrocyte-lineage cells increase after ICH,
especially in the peri-hematoma. a Oligodendrocyte-lineage cells of any
maturation state were identified using an antibody against the nuclear
antigen, Olig2 (red). Cell nuclei were stained with DAPI (blue), and the
enlarged inset shows an example of staining co-localization.
Representative images from 1 to 28 days after ICH show the
contralateral (undamaged) striatum, the peri-hematoma region, and the
striatum surrounding the peri-hematoma. Scale bar = 50 μm (main
panels), 10 μm (inset). Inset to right: Low-magnification image of
oligodendrocyte-lineage cells (Olig2; red) surrounding the hematoma at
7 days. Scale bar= 50 μm. b Time-dependent changes in the density of
oligodendrocyte-lineage cells were determined by counting double-
labeled Olig2+DAPI+ nuclei. Values represent mean ± SEM from three
rats at each time point, and the dashed line represents the mean for 1-
day saline controls (n= 3). Statistical comparisons were based on a one-
way ANOVA followed by Tukey’s post-hoc test. Comparisons show
differences: † from the preceding time point, # between ICH and 1 day
saline controls; one symbol p< 0.05, two symbols p< 0.01, three symbols
p < 0.001, four symbols p < 0.0001. Additional significant differences
that are not illustrated with symbols are as follows: (i) in the peri-
hematoma, 7 vs 1 and 28 days; (ii) in the surrounding striatum, 28 vs 1,
3, and 7 days; and (iii) in the contralateral striatum, 28 vs 1, 3, and 7 days
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nuclear protein present in all active phases of the cell cycle but
not in the G0 phase [32]. Because Olig2 and DAPI co-localize
in the nucleus (Fig. 3), we could readily identify proliferating
oligodendrocyte-lineage cells as those double-labeled for
Olig2 and Ki67. In general, many proliferating cells (Ki67+)
were present in the peri-hematoma region at 3 and 7 days
(Fig. 5a). The higher-magnification images (Fig. 5b) show
examples of proliferating (Ki67+) Olig2+ cells, some
oligodendrocyte-lineage cells not in active cell-cycle phases
(Ki67−Olig2+), and some proliferating cells that were not of
oligodendrocyte lineage (Ki67+Olig2−). Proliferating Olig2+
cells were then quantified in two ways: as the density of cells
double-labeled for Ki67 and as the percentage of Olig2+ cells
that had re-entered the cell cycle. In the peri-hematoma region,
their density increased ∼16-fold between 1 and 3 days and
then progressively declined by 14 days to the level seen at
1 day (Fig. 5c). Of note, increased proliferation of Olig2+ cells
preceded their maximal increase in density at 7 days (Fig. 3).
At 3 days, 55±5 % of the Olig2+ cells expressed Ki67, while
only 9±1 % did so at 7 days (Fig. 5d). In the surrounding
striatum, their proliferation showed a similar time course but
much lower density, and the proportion of proliferating Olig2+
cells was only 18±2% at 3 days. No proliferating Olig2+ cells
were detected in the striatum of saline-injected control rats or
the contralateral striatum of ICH animals (not shown). Next,
we addressed whether proliferating Olig2+ cells in the peri-
hematoma were likely to have simply migrated from the SVZ,
a site of oligodendrogenesis throughout life [33]. While pro-
liferating cells were present in the SVZ at each time point,
almost none of them were Olig2+ (Fig. 5a, b). Of those few
that were double-labeled, their numbers did not change be-
tween 1 and 28 days (not shown); thus, proliferation of
Olig2+ cells at the damage site is apparently important for their
increased density.
OPCs and Mature Oligodendrocytes Increase Transiently
in the Peri-hematoma, Preferentially Inside White-Matter
Tracts
As shown above, the density of oligodendrocyte-lineage cells
increased dramatically and peaked at 7 days, at which time
many were inside the damaged white-matter bundles (Figs. 3
and 4). However, in order to generate and repair myelin, they
must undergo maturation [34]; therefore, we next quantified
their maturation states. Immature oligodendrocyte precursor
cells (OPCs) were identified as cells with Olig2+ nuclei that
also stained for NG2 chondroitin sulfate proteoglycan [35]. It
was necessary to double-label the cells (see high-
magnification image in Fig. 6a) because activated microglia
and macrophages can also express NG2 [36]. In the undam-
aged contralateral striatum, there was no change in the density
of OPCs (NG2+Olig2+) compared with saline controls
(Fig. 6a, b). In contrast, in the peri-hematoma region, their
density increased dramatically at 3 and 7 days (∼8-fold at
7 days) and then decreased, reaching control levels by 28 days.
Sagittal sections showed a similar time-dependent increase in
OPCs, preferentially inside the white-matter bundles
(Fig. 6c, d). In the surrounding striatum, there was a much
smaller increase, with statistical significance only at 3 days
(Fig. 6b).
To quantify the density of mature oligodendrocytes, cells
were double-labeled for Olig2 and CC-1. CC-1 labels adeno-
matous polyposis coli (APC), a tumor suppressor protein that
is present in the cell body of mature oligodendrocytes and
thought to regulate their adhesive properties [37]. Double-
labeling for CC-1 and Olig2 is illustrated in the high-
magnification inset in Fig. 7a. In the peri-hematoma region,
the density of mature oligodendrocytes increased with time,
reached a peak at 7 days that was ∼7-fold higher than that of
saline controls (Fig. 7a, b), and then declined. This time-
dependen t p ro f i l e was s imi l a r to tha t o f to t a l
oligodendrocyte-lineage cells (Fig. 3b) and OPCs (Fig. 6b),
but the density of mature cells was higher than that of OPCs.
Fig. 4 Oligodendrocyte-lineage cells preferentially increase inside
white-matter bundles. a Representative images from sagittal sections
taken from the peri-hematoma region, with myelin bundles labeled with
MBP (green) and oligodendrocyte-lineage cells of any maturation state
labeled with Olig2 (red). Scale bar= 50 μm and applies to all panels. b
Density of Olig2+ cells inside or outside white-matter bundles in the peri-
hematoma region. Values are mean± SEM from four rats at each time
point after ICH. The dashed lines indicate mean values for 1-day saline
controls (n= 3) for oligodendrocyte-lineage cells inside (red) and outside
bundles (black). Statistical comparisons were based on a two-way
ANOVA followed by Tukey’s post-hoc test. Comparisons show
differences: † from the preceding time point, # from the saline control,
* between those inside and outside the bundles; one symbol p< 0.05, two
symbols p< 0.01, three symbols p< 0.001
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Fig. 5 Oligodendrocyte-lineage cells proliferate in the damaged
striatum, particularly in the peri-hematoma region. a Representative
images show oligodendrocyte-lineage cells labeled for Olig2 (green),
proliferating cells stained with an antibody against Ki67 (red), and
nuclei labeled with DAPI (blue). Images were taken from the ipsilateral
side in the peri-hematoma region (left panels), surrounding striatum
(middle), and SVZ (right). Scale bar= 50 μm and applies to all panels.
b Higher-magnification images of typical single-, double-, and triple-
stained nuclei in each region at 3 days after ICH. c Density of
proliferating oligodendrocyte-lineage cells (i.e., cells with Olig2+Ki67+
nuclei) in the peri-hematoma and surrounding striatum from 1 to 28 days
after ICH. d Percentage of oligodendrocyte-lineage cells that were
proliferating. Values are mean ± SEM from three rats at each time.
Statistical comparisons were based on a one-way ANOVA followed by
Tukey’s post-hoc test and show differences: † from the preceding time
point; one symbol p < 0.05, two symbols p < 0.01, three symbols
p < 0.001. Additional significant differences in the density of
proliferating oligodendrocyte-lineage cells that are not indicated with
symbols were as follows: (i) in the peri-hematoma, 1 vs 7 days, 3 vs
14 days, and 28 vs 3 and 7 days; and (ii) in the surrounding striatum, 3
vs 14 and 28 days. For the percentage of oligodendrocyte-lineage cells
that were Ki67+, all time points were significantly different from 3 days in
both the peri-hematoma and surrounding striatum
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In the surrounding striatum, mature oligodendrocytes in-
creased at 7 and 14 days and then decreased to control levels
at 28 days. In the undamaged contralateral striatum, the den-
sity of mature oligodendrocytes was increased by 2–3-fold as
early as 1 day and remained elevated for at least 14 days
(Fig. 7a, b). Because there was no increase in immature
OPCs (Fig. 6b) or proliferating Olig2+ cells, this suggests that
the cells migrated into the striatum from other regions soon
after ICH. Finally, mature oligodendrocytes increased
preferentially inside the white-matter bundles (Fig. 7c, d), as
was shown for total oligodendrocyte-lineage cells (Fig. 4) and
OPCs (Fig. 6). However, the greatest increases in mature cells
were at 7 and 14 days (Fig. 7) compared with 3 and 7 days for
OPCs (Fig. 6). Together with the proliferation data (Fig. 5),
these observations provide evidence for local replenishment
of both immature OPCs and mature oligodendrocytes in the
peri-hematoma region, and preferentially inside white-matter
tracts.
Fig. 6 Oligodendrocyte precursor cells (OPCs) increase preferentially in
the peri-hematoma and inside white-matter bundles. a OPCs were
identified as cells with Olig2+ nuclei (red) that were double-labeled
with an antibody against NG2 chondroitin sulfate proteoglycan (green).
Representative images were taken from the contralateral striatum, and the
peri-hematoma region and the surrounding striatum on the ipsilateral side.
The higher-magnification inset shows a typical OPC, with an Olig2+
nucleus surrounded by NG2. Scale bar = 50 μm (main panels), 10 μm
(inset). b Time-dependent changes in density of OPCs (Olig2+NG2+
cells). Values represent mean ± SEM from three rats at each time point,
and the dashed line represents the mean for 1-day saline controls (n = 3).
Statistical comparisons were based on a one-way ANOVA followed by
Tukey’s post-hoc test. Comparisons show differences: † from the
preceding time point, # from the 1-day saline control; one symbol
p< 0.05, two symbols p< 0.01, three symbols p < 0.001, four symbols
p < 0.0001. Additional significant differences that are not shown with
symbols are as follows: (i) in the peri-hematoma, 7 vs 1 and 28 days, 3
vs 14 and 28 days; and (ii) in the surrounding striatum, 3 vs 14 and
28 days. c Representative images from sagittal sections taken from the
peri-hematoma region were triple-stained for Olig2 (red), NG2 (green),
and myelin basic protein (MBP; blue). Scale bar= 50 μm and applies to
all panels. dDensity of OPCs (Olig2+NG2+ cells) inside or outside white-
matter bundles in the peri-hematoma region. Values are mean ± SEM
from four rats at each time point after ICH. The dashed lines indicate
mean levels for 1-day saline controls (n= 3) for OPCs inside (red) and
outside the bundles (black). Statistical comparisons were based on a two-
way ANOVA, followed by Tukey’s post-hoc test. Comparisons show
differences: † from the preceding time point, # from the saline control,
* between those inside and outside the bundles; one symbol p< 0.05, two
symbols p< 0.01, three symbols p< 0.001
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Discussion
White-matter damage often occurs after acute CNS injury [38]
and is considered an important predictor of the outcome, in-
cluding after stroke [39, 40]. After intracerebral hemorrhage
(ICH), significant white-matter damage was seen in CT scans
of 77 % of patients [9] and large white-matter lesions were
associated with severe Glasgow Coma Scale scores [40]. MRI
showed that white-matter hyper-intensity volumes were
higher after ICH than after ischemic strokes [41]. In most
experimental stroke studies that consider white matter, the
focus has been on ischemia and on treatment targets ranging
from reducing immediate damage to promoting endogenous
repair/regeneration to replacing cells using exogenous
sources. In evaluating approaches for repairing white matter,
it is important to know the fate of axons and oligodendrocytes
but almost nothing is known about these aspects after ICH.
We found only one previous study, which showed that after
experimental ICH in the mouse cortex, staining of mature
oligodendrocytes with RIP antibody (which recognizes 2′,3′-
cyclic nucleotide 3′-phosphodiesterase; CNPase) decreased at
7 days [42]. The location with respect to the hematoma was
not stated, and temporal changes, proliferation, and differen-
tiation of oligodendrocyte-lineage cells were not addressed.
The present study appears to be the first to address the fate
of oligodendrocyte-lineage cells after ICH in the rat. We fo-
cused on the peri-hematoma region and surrounding striatum
because tissue is immediately damaged inside the hematoma
and is unlikely to be salvageable [43]. We will discuss each
aspect in light of the limited literature.
We used coronal and sagittal sections to assess white-
matter tracts that are comprised of myelinated corticostriatal
axons. In this model, we previously quantified a progressive
loss of normal myelin and accumulation of damagedmyelin in
the first week [16, 17, 27]. Here, similar progressive myelin
damage was seen but a new finding was that both axons and
oligodendrocytes survived in the peri-hematoma region and
surrounding striatum for at least 28 days, the longest time
tested. Initially, as white-matter damage progressed during
the first week, the myelinated tracts in the peri-hematoma
region became swollen, which is consistent with previously
identified white-matter edema [44]. The bundles became
Fig. 6 (continued)
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increasingly fragmented during the first week but still recog-
nizable, and extensive, diffuse neurofilament staining
remained at 7 days. In earlier ICH studies, we observed tran-
sient accumulation of amyloid precursor protein (APP) and
SC1/hevin within axons in the peri-hematoma at 1 and 3 days
[16, 17, 27]. At the time, we noted that accumulation of these
molecules indicates impaired axoplasmic transport but does
not mean the axons are irreversibly damaged. We had not
previously examined times beyond 7 days and were surprised
to find that at 14 and 28 days, many discrete myelinated bun-
dles of axons were again present and appeared normal. While
it is possible that severely fragmented tracts had been re-
moved, there was no apparent decrease in the number of bun-
dles compared with the undamaged striatum. Instead, in sag-
ittal sections, some bundles appeared thinner (a characteristic
of regenerated myelin [45]), and this is consistent with an
observation at 100 days after autologous blood injection into
the rat striatum [46]. An earlier ICH study in mice reported
fewer corticostriatal axons at 7 days, but an increase at 9 weeks
[47].
The present finding that axon bundles were poorly orga-
nized at 7 days but well organized at 14 and 28 days suggests
Fig. 7 Mature oligodendrocytes increase after ICH, especially inside
white-matter bundles in the peri-hematoma. a Mature oligodendrocytes
were identified as cells with Olig2+ nuclei (red) that were double-labeled
with an antibody against adenomatous polyposis coli (APC, also called
CC-1; green). Representative images were taken from the contralateral
striatum, and the peri-hematoma and surrounding striatum on the
ipsilateral side. The higher-magnification inset shows a typical mature
oligodendrocyte with an Olig2+ nucleus surrounded by CC-1. Scale
bar= 50 μm (main panels), 10 μm (inset). b Time-dependent changes
by density of mature oligodendrocytes (Olig2+CC-1+ cells). Values
represent mean ± SEM from three rats at each time point, and the
dashed line represents the mean for 1-day saline controls (n = 3).
Statistical comparisons were based on a one-way ANOVA followed by
Tukey’s post-hoc test. Comparisons show differences: † from the
preceding time point, # from the 1-day saline control; one symbol
p < 0.05, two symbols p < 0.01, three symbols p < 0.001. Additional
significant differences that are not shown with symbols are as follows:
(i) in the peri-hematoma, 7 vs 1 and 28 days; and (ii) in the surrounding
striatum, 7 vs 1 and 28 days and 14 vs 1 and 3 days. c Representative
images from sagittal sections from the peri-hematoma region that were
triple-stained for Olig2 (red), CC-1 (green), and myelin basic protein
(MBP; blue). Scale bar= 50 μm and applies to all panels. d Density of
mature oligodendrocytes (Olig2+/CC-1+) inside or outside white-matter
bundles in the peri-hematoma region. Values are mean ± SEM from four
rats at each time point. The dashed lines indicate mean values for 1-day
saline controls (n = 3) for oligodendrocytes inside (red) and outside the
bundles (black). Statistical comparisons were based on a two-way
ANOVA, followed by Tukey’s post-hoc test. Comparisons show
differences: † from the preceding time point, # from the saline control,
* between those inside and outside the bundles; one symbol p< 0.05, two
symbols p< 0.01, three symbols p< 0.001
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that some recovery had occurred. While a large battery of
tests is needed to assess neurological outcomes after dam-
age to the striatum [48], several studies of collagenase-
induced ICH in the rat show varying degrees of spontane-
ous recovery. Over several weeks, ICH animals exhibited
recovery in several motor and cognitive tasks [48–51] but
still had some sensorimotor deficits up to 8 weeks [50, 51].
Not surprisingly, greater recovery is generally seen for
small- to medium-sized lesions [49]: the size range in the
present study. In the most similar study, motor deficits had
resolved at 30 days, as judged by the composite neurolog-
ical deficit scale, which assesses spontaneous ipsilateral
circling, hind limb retraction, bilateral forepaw grasp,
beam walking ability, and forelimb flexion [48].
The main emphasis of this study was on the fate of
oligodendrocyte-lineage cells. In the peri-hematoma region,
both immature OPCs and mature oligodendrocytes were in-
creased substantially from 1 to 7 days and preferentially
enriched inside white-matter bundles. They were also
increased throughout the surrounding striatum. In both loca-
tions, their density then declined from 14 to 28 days. By
7 days, both immature OPCs and mature oligodendrocytes
formed a ring around the hematoma, with a similar distribu-
tion to the peri-hematoma ring of activated microglia/
macrophages [17]. Moreover, the immune cells were prefer-
entially inside white-matter bundles that labeled for damaged
myelin basic protein. This raises important questions for fu-
ture study. Are activated microglia/macrophages phagocytos-
ing myelin debris to promote re-myelination? Do they initially
support survival and proliferation of oligodendrocyte-lineage
cells and then, at later times, kill and remove excess cells?
Another possibility is that the decline in oligodendrocyte-
lineage cells at later times results from toxic effects of blood
components. In vitro, blood proteins can suppress migration
of OPCs and thrombin can suppress OPC differentiation [52].
Iron liberated from ruptured erythrocytes causes oxidative
stress [24, 53], and iron remains elevated for at least 1 month
in the collagenase ICH model [24, 54].
Fig. 7 (continued)
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In principle, the increase in the density of oligodendrocyte-
lineage cells in the peri-hematoma and surrounding striatum
after ICH could be due to proliferation, migration from other
areas, or both. In the present study, the striatum contained
many proliferating oligodendrocyte-lineage cells but very
few were seen in the subventricular zone (SVZ). Similarly,
in rodent models of ischemic stroke, proliferating NG2+
OPCs were also prevalent in the peri-infarct region, maximal
at 7 days [55, 56], and then decreased at 28 days [56]. The
SVZ is considered a source of neural progenitor cells that
migrate out and can differentiate into oligodendrocytes, but
previous ICH studies have investigated the SVZ only from a
neurogenes i s pe r spec t ive [57–62] . The s i t e o f
oligodendrogenesis might also depend on the disease model
and where the damage is located. For instance, in
Huntington’s disease, oligodendrocyte-lineage cells prolifer-
ated within the striatum [63] but not in the SVZ [63–66]. After
ischemic stroke (murine middle cerebral artery occlusion
model), fate-mapping showed some SVZ-derived oligoden-
drocytes in the striatum [67, 68]. After de-myelination of the
mouse corpus callosum, OPC proliferation was seen within
the SVZ [33, 69].
The oligodendrocyte density also increased in the contra-
lateral striatum from 1 to 14 days, but we did not detect pro-
liferating OPCs at any time. In the future, with optical tagging
or genetic markers, it might be possible to determine whether
their source is within the striatum or from the corpus callosum,
SVZ, or another location. We could not find previous publi-
cations addressing oligodendrocyte responses in the contralat-
eral side after ICH. However, there are numerous indications
that the contralateral hemisphere does respond after ICH, i.e.,
changes in gene expression [18, 70], enhanced dendritic ar-
borization [23], loss of corticostriatal axons [47], and in-
creased axial diffusivity [71].
The substantial increase in OPC proliferation suggests that
ICH upregulates mitogens in the peri-hematoma and sur-
rounding striatum. There are several good candidates.
Insulin-like growth factor-1 (IGF-1) stimulates OPC prolifer-
ation in vitro [72]. Platelet-derived growth factor (PDGF) ac-
tivates the α receptor (PDGFRα) on OPCs and increases their
proliferation and survival in vitro [73–75] and in organotypic
slices [76]. Fibroblast growth factor-2 (FGF-2) stimulates
OPC proliferation [77] and upregulates their expression of
PDGFRα, which prevents them frommaturing and, thus, pro-
longs their responses to PDGF [78]. In the future, it would be
interesting to examine the spatial and temporal expression of
these potential mitogens after ICH. There appears to be very
limited information about their expression after ICH, with data
from two microarray studies. Within 24 h after ICH, FGF-2
was ∼1.5-fold lower in the peri-hematoma region of four ICH
patients [79], and the FGF-2 receptor, FGF2rb, was ∼2-fold
lower in the striatum and cortex in the rat autologous blood-
injection model [80]. Interestingly, FGF-2 supplementation
reduced edema and improved some motor functions in the
collagenase- and autologous-blood injection ICH models in
mice [81].
Mature oligodendrocytes are required for re-myelination
[82]; thus, an important finding was that more than half the
oligodendrocyte-lineage cells in the ipsilateral striatum were
mature (CC-1+) by 7 days. This time course is consistent with
a 3- to 4-day period for NG2+ OPCs to differentiate into ma-
ture CC-1+ oligodendrocytes after acute demyelination in
forebrain slice cultures [83]. CC-1 does not distinguish if these
cells are actively myelinating. Future studies will need to ex-
amine myelination markers and re-myelination itself. Our re-
sults suggest that differentiation factors are present early after
ICH, and there are several good candidates. Brain-derived
neurotrophic factor (BDNF) can stimulate OPC differentiation
in vitro, during development and after white-matter ischemia
in mice [84–87], and after subcortical ischemia in rats [88].
Other potential OPC differentiation factors are transforming
growth factor beta (TGF-β) [89], IGF-1 [72, 90], thyroid hor-
mone [82], and epidermal growth factor (EGF) [91, 92].
Microglia can produce these and other mediators that promote
oligodendrocyte proliferation and differentiation in vitro and
in other demyelination models in vivo [93–96]. Again, there is
limited data on expression of these molecules after ICH. Most
of the published data concern TGF-β and BDNF. In the first
week after collagenase-induced ICH in the rat, the damaged
striatum showed increases in transcript expression for TGF-β
[18, 70] and BDNF (S Lively and LC Schlichter, unpublished
results). Microarray data from peri-hematomal tissue of four
ICH patients showed a nearly 3-fold increase in TGF-β tran-
scripts in the first day [97]. In the rat autologous blood-
injection model, BDNF protein did not change in the peri-
hematoma at 7 days [98]. Clearly, future studies will be need-
ed to determine the spatiotemporal expression, cellular
sources, and contributions of potential oligodendrocyte differ-
entiation factors after ICH.
Summary and Conclusions Strategies to treat white-matter
injury focus on reducing oligodendrocyte loss, adding growth
factors to promote their proliferation, maturation, and re-
myelination, or supplementing with exogenous stem cells
[99, 100]. Although stem cell replacement is used in experi-
mental studies of ischemic stroke, and injected mesenchymal
stem cells can differentiate into oligodendrocytes (as well as
neurons and astrocytes [101]), there is surprisingly little evi-
dence supporting any of these approaches after ICH. This is
apparently the first study to examine and quantify the spatial
and temporal distribution of oligodendrocyte-lineage cells,
and their proliferation and maturation after experimental
ICH. There are several salient findings. (i) Axons and oligo-
dendrocytes survived for at least a month in the peri-
hematoma region and surrounding striatum, and by 2 weeks,
there were signs that the myelinated corticostriatal axon tracts
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were recovering. (ii) The density of both immature OPCs and
mature oligodendrocytes increased dramatically in the peri-
hematoma region for the first week and then declined to about
control levels. Their source was likely local because consid-
erable proliferation of oligodendrocyte-lineage cells was seen
in the peri-hematoma and surrounding striatum (peak at
3 days) but not in the subventricular zone during the first
month. (iii) Both immature OPCs and mature oligodendro-
cytes were present throughout the first month, and when their
density peaked at about 1 week, they were preferentially lo-
cated inside white-matter bundles. Thus, endogenous cells
that are required for re-myelination are present in the right
place for the first month after ICH. These results provide use-
ful benchmarks for assessing potential therapies to rescue the
tissue surrounding the hemorrhage, for further investigating
the cellular basis of damage after ICH, and for improving
white-matter recovery and function. Future studies will need
to address whether the new oligodendrocytes are essential for
re-myelinating axons and whether these axons are functional-
ly integrated into the proper circuitry.
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